Company Analysis MicroPort CardioFlow Medtech Corporation
1. Summary
Advantages
- Price (0.1293 $) is less than fair price (0.2495 $)
Disadvantages
- Dividends (0%) are below the sector average (2.17%).
- The stock's return over the last year (-60.91%) is lower than the sector average (2.8%).
- The company's current efficiency (ROE=-2.85%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| MicroPort CardioFlow Medtech Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.2% | 1.4% | 0.7% |
| 90 days | -0.2% | -1.5% | 7.6% |
| 1 year | -60.9% | 2.8% | 11.7% |
MROPF vs Sector: MicroPort CardioFlow Medtech Corporation has significantly underperformed the "Healthcare" sector by -63.71% over the past year.
MROPF vs Market: MicroPort CardioFlow Medtech Corporation has significantly underperformed the market by -72.59% over the past year.
Stable price: MROPF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: MROPF with weekly volatility of -1.17% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.1293 $) is lower than the fair price (0.2495 $).
Price significantly below the fair price: The current price (0.1293 $) is 93% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (59.91).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.3427) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (0.3427) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (16.9) is higher than that of the sector as a whole (3.69).
P/S vs Market: The company's P/S indicator (16.9) is higher than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (40.07).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.31% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.31%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.24%).
5.4. ROE
ROE vs Sector: The company's ROE (-2.85%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (-2.85%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.57%) is lower than that of the sector as a whole (6.05%).
ROA vs Market: The company's ROA (-2.57%) is lower than that of the market as a whole (29.37%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
